CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.26B, above the global median of $1.15B
- FinancialsAltman Z-Score 6.09: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.90%
Annual Rate
CNY 0.18Paid annual
Payout Ratio
24.1%Sustainable
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.48BCNY1.26B · vs all stocks (USD)
Trailing P/E
48.31xvs Medical Devices peers
Revenue (TTM)
2.36BCNY350.45M · vs all stocks (USD)
Profit Margin
7.53%vs Medical Devices peers
Beta
-0.4910xvs all stocks
52-Week Change
-43.98%vs all stocks
Market Capitalization
8.48BCNY1.26B · vs all stocks (USD)
Enterprise Value
7.70BCNY1.14B · vs all stocks (USD)
Trailing P/E
48.31xvs Medical Devices peers
Forward P/E
20.42xvs Medical Devices peers
Price to Sales (TTM)
3.65xvs Medical Devices peers
Price to Book (MRQ)
2.68xvs Medical Devices peers
Enterprise to Revenue
3.26xvs Medical Devices peers
Enterprise to EBITDA
36.46xvs Medical Devices peers
Gross Margin
61.44%vs Medical Devices peers
Profit Margin
7.53%vs Medical Devices peers
Operating Margin
0.79%vs Medical Devices peers
Return on Assets (TTM)
1.91%vs Medical Devices peers
Return on Equity (TTM)
5.56%vs Medical Devices peers
Revenue (TTM)
2.36BCNY350.45M · vs all stocks (USD)
Revenue per Share (TTM)
5.50CNYUpdated Aug 19, 2026Quarterly Revenue Growth
11.80%vs Medical Devices peers
Gross Profit (TTM)
1.41BCNY209.81M · vs all stocks (USD)
EBITDA (TTM)
325.37MCNY48.32M · vs all stocks (USD)
Net Income (TTM)
177.60MCNY26.38M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.92%vs Medical Devices peers
Operating Cash Flow (TTM)
96.92MCNY14.39M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-30.58MCNY-4.54M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.90%vs all stocks
Payout Ratio
24.13%vs Medical Devices peers
Revenue
2.31BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
877.69MCNYFY2025 · Dec 31, 2025Gross Profit
1.43BCNYFY2025 · Dec 31, 2025Operating Income
184.45MCNY27.39M · vs all stocks (USD)
Pre-tax Income
164.19MCNYFY2025 · Dec 31, 2025Income Tax Expense
-33.09MCNYFY2025 · Dec 31, 2025Net Income
197.28MCNYFY2025 · Dec 31, 2025EBIT
168.35MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
325.37MCNYFY2025 · Dec 31, 2025Research & Development
495.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
283.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
21.27MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
35.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
428.87MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
428.87MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
197.28MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-193.94MCNYFY2025 · Dec 31, 2025Free Cash Flow
-336.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
197.28MCNYFY2025 · Dec 31, 2025Other Non-cash Items
8.19MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-72.76MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-326.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-142.11MCNYFY2025 · Dec 31, 2025Sale of Investments
5.75MCNYFY2025 · Dec 31, 2025Other Investing Activity
-72.10MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-208.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
230.68MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-262.09MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-47.23MCNYFY2025 · Dec 31, 2025Other Financing Charges
-11.77MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-90.41MCNYFY2025 · Dec 31, 2025Shares Outstanding
432.71MSharesUpdated Aug 19, 2026Float Shares
187.35MSharesUpdated Aug 19, 2026% Held by Insiders
56.35%vs all stocks
% Held by Institutions
11.39%vs all stocks
Total Cash (MRQ)
1.42BCNY210.89M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.30CNYUpdated Aug 19, 2026Total Debt (MRQ)
275.39MCNY40.90M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0844xvs Medical Devices peers
Current Ratio (MRQ)
2.96xvs Medical Devices peers
Book Value per Share (MRQ)
7.58CNYUpdated Aug 19, 2026Total Assets
4.41BCNY654.43M · vs all stocks (USD)
Total Current Assets
2.82BCNYFY2025 · Dec 31, 2025Total Liabilities
1.14BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.59BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
123.65MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.02BCNYFY2025 · Dec 31, 2025Cash
1.43BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.43BCNYFY2025 · Dec 31, 2025Other Short-term Investments
237.16MCNYFY2025 · Dec 31, 2025Accounts Receivable
300.53MCNYFY2025 · Dec 31, 2025Inventory
763.60MCNYFY2025 · Dec 31, 2025Accounts Payable
367.11MCNYFY2025 · Dec 31, 2025Short-term Debt
245.01MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.13MCNYFY2025 · Dec 31, 2025Long-term Debt
65.13MCNYFY2025 · Dec 31, 2025Common Stock (Book)
432.71MCNYFY2025 · Dec 31, 2025Retained Earnings
1.57BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.26BCNY484.55M · vs all stocks (USD)
Treasury Stock
120.03MCNYFY2025 · Dec 31, 202552-Week Low
17.20CNYUpdated Aug 19, 202652-Week High
37.73CNYUpdated Aug 19, 202652-Week Change
-43.98%vs all stocks
Beta
-0.4910xvs all stocks
50-Day MA
19.40CNYUpdated Aug 19, 2026200-Day MA
24.48CNYUpdated Aug 19, 2026Avg 10-Day Volume
4.53MSharesUpdated Aug 19, 2026Avg 30-Day Volume
5.86MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.4200CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: 0.08
Financial Health
Altman Z-Score 6.09: safe zoneNotable
Altman Z-Score: 6.09
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.26B, above the global median of $1.15BNotable
Market cap (USD): 1,260,044,418.738Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Corvus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jade Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tianjin Ringpu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MannKind Corporation
Tier 1ProductionApproval-Gated PipelineRule
Hubei Hongyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Taienkang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bio-Thera Solutions Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Liaoning Chengda Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Inhibrx Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Xianju Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Medy-Tox Inc.
2 interpretationsMinimal Tax and Interest DragHigh Retained Earnings With Profitability And Equity
Soulbrain Holdings Co., Ltd.
2 interpretationsMinimal Tax and Interest DragHigh Retained Earnings With Profitability And Equity
Escorts Kubota Ltd.
2 interpretationsMinimal Tax and Interest DragHigh Retained Earnings With Profitability And Equity